Skip to main content

Alpha Tau Medical Ltd.

DRTS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001871321

In the last 90 days, Alpha Tau Medical Ltd. insiders filed 0 open-market purchases and 4 sales; 74 institutions reported holding it in 13F filings for Q2 2026, worth $100.1M in total; ARK Invest is the only superinvestor holding it.

Other share classesDRTSW

Q2 2023 vs. Q1 2023

How the institutions holding Alpha Tau Medical Ltd. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of DRTS: Q1 2023 compared with Q2 2023
MeasureQ1 2023Of which not filed for Q2 2023Q2 2023Change
Holders16120+5
Shares652.1K66.3K948.6K+362.8K (+61.9%)
Value$1.87M$190.4K$4.11M+$2.43M (+144.4%)

1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (7)

Institutions that held Alpha Tau Medical Ltd. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to DRTS in Q2 2023
InstitutionSharesValue% of portfolio
Corbin Capital Partners, L.P.260,109$1.14M1.05%
Atalaya Capital Management LP73,742$322.3K0.16%
Grey Street Capital, LLC23,323$101.9K0.05%
Levin Capital Strategies, L.P.20,000$87.4K0.01%
Summit Trail Advisors, LLC10,270$44.9K0.00%
Activest Wealth Management4,053$28.4K0.02%
Tuttle Tactical Management12,221$4.83K0.02%

Sold out (2)

Institutions that held Alpha Tau Medical Ltd. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of DRTS in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
FMR LLC362,046$1.04M
UBS Group AG1,292$3.71K

Not filed for Q2 2023 yet (1)

Institutions that held Alpha Tau Medical Ltd. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding DRTS in Q1 2023 that haven't filed for Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
ETF Managers Group, LLC66,326$190.4K